Agilent CEO Sees Demand From Small Biotech Nearly ‘Shut Down.’ The Stock Tumbles.
Analysts downgraded the laboratory instruments maker's stock after it trimmed its profit outlook for the year on a loss of demand.
Analysts downgraded the laboratory instruments maker's stock after it trimmed its profit outlook for the year on a loss of demand.